TrialFrontiers in immunology2021

Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE.

Morgane Humbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.